Faculty:

David Wilber, M.D. Co-Chair
Loyola University Medical Center, Chicago, IL

Joseph Akar, M.D., Ph.D. Co-Chair
Loyola University Medical Center, Chicago, IL

Andrea Natale, M.D.
The Cleveland Clinic, Cleveland, OH

Carlo Pappone, M.D., Ph.D.
San Raffalel University Hospital, Milan, ITALY

Eric Prystowsky, M.D.
The Care Group, Indianapolis, IN

---

Topics:

Ablation of PAF: Risks, Benefits and Outcomes
Andrea Natale, M.D.

Chronic AF: The Last Frontier
Carlo Pappone, M.D., Ph.D.

Randomized Trials of AF Ablation
David Wilber, M.D.

New AF Guidelines: Where does Ablation fit in?
Eric Prystowsky, M.D.

---

Target Audience:

This activity is designed for physicians and nurses who treat patients with atrial fibrillation.

---

Learning Objectives:

Upon completion of this educational activity, participants should be able to:

• Discuss the role of Catheter Ablation for the treatment of Atrial Fibrillation
• Disseminate various randomized trial results for Atrial Fibrillation Ablation
• Summarize recommendations for Paroxysmal Atrial Fibrillation Ablation
• Discuss key findings from latest Atrial Fibrillation Guidelines
• Integrate the latest recommendations on the use of Atrial Imaging Techniques and Technologies for the guidance of Atrial Fibrillation Ablation.

---

Accreditation:

MD/DO:
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s) ™.

Each physician should claim only those credits that he/she actually spent in the educational activity. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

Nurses:
ANCC: ANCC: North American Center for Continuing Medical Education is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 2 contact hour(s). Provider #: 110-3-E-03.

Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 2 contact hours.

---

Faculty Disclosures:

All faculty participating in Continuing Education programs sponsored by the North American Center for Continuing Medical Education are expected to disclose to the meeting audience any real or apparent conflict(s) of interest related to the content of their presentation.  It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.
 
Doctor Akar has disclosed that he has no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of his presentation.
 
Doctor Natale has disclosed that she has received grant/research support from Biosense, St. Jude and Accuson.
 
Doctor Pappone has disclosed that he has received grant/research support from St. Jude Medical, J&J and Boston Scientific.
 
Doctor Prystowski has disclosed that he has received grant/research support from Sanofi-Aventis. He is a consultant for Sanofi-Aventis, Stereotaxis, Bard and Reliant. He is a major stock shareholder in CardioNet.
 
Doctor Wilber has disclosed that he has received grant/research support and is a consultant to Biosense Webster and Bard.

---

Commercial Supporter:

This activity is supported by an educational grant from Biosense Webster Inc.

---

Sponsor:

Sponsored by the North American Center for Continuing Medical Education (NACCME).